ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Transdermal Testosterone Market Research Report 2024
Published Date: January 2024
|
Report Code: QYRE-Auto-33O6772
Home | Market Reports | Health| Pharmacy
Global Transdermal Testosterone Market Insights Forecast to 2028
BUY CHAPTERS

Global Transdermal Testosterone Market Research Report 2024

Code: QYRE-Auto-33O6772
Report
January 2024
Pages:91
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
AbbVie
TEVA
Perrigo
Endo Pharmaceuticals
Acerus Pharmaceuticals
Lupin Ltd
Dr. Reddy’s Laboratories
Upsher-Smith Laboratories
Allergan plc
Cipla Ltd

Transdermal Testosterone Market Size

The global Transdermal Testosterone market was valued at US$ 589 million in 2023 and is anticipated to reach US$ 923.9 million by 2030, witnessing a CAGR of 7.4% during the forecast period 2024-2030.

Transdermal Testosterone Market

Transdermal Testosterone Market

Transdermal Testosterone contains testosterone. It is used for hormone replacement in men who are not able to produce enough testosterone (e.g., hypogonadism). This medication is absorbed through the skin, enters your bloodstream, and helps your body reach normal testosterone levels.
North American market for Transdermal Testosterone is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Transdermal Testosterone is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Transdermal Testosterone include AbbVie, Teva, Perrigo, Endo Pharmaceuticals, Acerus Pharmaceuticals, Lupin, Dr. Reddy's Laboratories, Upsher-Smith Laboratories and Allergan, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Transdermal Testosterone, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Transdermal Testosterone.

Report Scope

The Transdermal Testosterone market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Transdermal Testosterone market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Transdermal Testosterone manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Transdermal Testosterone Market Report

Report Metric Details
Report Name Transdermal Testosterone Market
Accounted market size in 2023 US$ 589 million
Forecasted market size in 2030 US$ 923.9 million
CAGR 7.4%
Base Year 2023
Forecasted years 2024 - 2030
Segment by Type
  • Gel
  • Patch
Segment by Application
  • Primary Hypogonadism
  • Hypogonadotropic Hypogonadism
  • Late-Onset Hypogonadism
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company AbbVie, Teva, Perrigo, Endo Pharmaceuticals, Acerus Pharmaceuticals, Lupin, Dr. Reddy's Laboratories, Upsher-Smith Laboratories, Allergan, Cipla Inc.
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Transdermal Testosterone manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Transdermal Testosterone in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Transdermal Testosterone Market growing?

Ans: The Transdermal Testosterone Market witnessing a CAGR of 7.4% during the forecast period 2024-2030.

What is the Transdermal Testosterone Market size in 2030?

Ans: The Transdermal Testosterone Market size in 2030 will be US$ 923.9 million.

Who are the main players in the Transdermal Testosterone Market report?

Ans: The main players in the Transdermal Testosterone Market are AbbVie, Teva, Perrigo, Endo Pharmaceuticals, Acerus Pharmaceuticals, Lupin, Dr. Reddy's Laboratories, Upsher-Smith Laboratories, Allergan, Cipla Inc.

What are the Application segmentation covered in the Transdermal Testosterone Market report?

Ans: The Applications covered in the Transdermal Testosterone Market report are Primary Hypogonadism, Hypogonadotropic Hypogonadism, Late-Onset Hypogonadism

What are the Type segmentation covered in the Transdermal Testosterone Market report?

Ans: The Types covered in the Transdermal Testosterone Market report are Gel, Patch

1 Transdermal Testosterone Market Overview
1.1 Product Overview and Scope of Transdermal Testosterone
1.2 Transdermal Testosterone Segment by Type
1.2.1 Global Transdermal Testosterone Market Value Comparison by Type (2024-2030)
1.2.2 Gel
1.2.3 Patch
1.3 Transdermal Testosterone Segment by Application
1.3.1 Global Transdermal Testosterone Market Value by Application: (2024-2030)
1.3.2 Primary Hypogonadism
1.3.3 Hypogonadotropic Hypogonadism
1.3.4 Late-Onset Hypogonadism
1.4 Global Transdermal Testosterone Market Size Estimates and Forecasts
1.4.1 Global Transdermal Testosterone Revenue 2019-2030
1.4.2 Global Transdermal Testosterone Sales 2019-2030
1.4.3 Global Transdermal Testosterone Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Transdermal Testosterone Market Competition by Manufacturers
2.1 Global Transdermal Testosterone Sales Market Share by Manufacturers (2019-2024)
2.2 Global Transdermal Testosterone Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Transdermal Testosterone Average Price by Manufacturers (2019-2024)
2.4 Global Transdermal Testosterone Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Transdermal Testosterone, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Transdermal Testosterone, Product Type & Application
2.7 Transdermal Testosterone Market Competitive Situation and Trends
2.7.1 Transdermal Testosterone Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Transdermal Testosterone Players Market Share by Revenue
2.7.3 Global Transdermal Testosterone Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Transdermal Testosterone Retrospective Market Scenario by Region
3.1 Global Transdermal Testosterone Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Transdermal Testosterone Global Transdermal Testosterone Sales by Region: 2019-2030
3.2.1 Global Transdermal Testosterone Sales by Region: 2019-2024
3.2.2 Global Transdermal Testosterone Sales by Region: 2025-2030
3.3 Global Transdermal Testosterone Global Transdermal Testosterone Revenue by Region: 2019-2030
3.3.1 Global Transdermal Testosterone Revenue by Region: 2019-2024
3.3.2 Global Transdermal Testosterone Revenue by Region: 2025-2030
3.4 North America Transdermal Testosterone Market Facts & Figures by Country
3.4.1 North America Transdermal Testosterone Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Transdermal Testosterone Sales by Country (2019-2030)
3.4.3 North America Transdermal Testosterone Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Transdermal Testosterone Market Facts & Figures by Country
3.5.1 Europe Transdermal Testosterone Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Transdermal Testosterone Sales by Country (2019-2030)
3.5.3 Europe Transdermal Testosterone Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Transdermal Testosterone Market Facts & Figures by Country
3.6.1 Asia Pacific Transdermal Testosterone Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Transdermal Testosterone Sales by Country (2019-2030)
3.6.3 Asia Pacific Transdermal Testosterone Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Transdermal Testosterone Market Facts & Figures by Country
3.7.1 Latin America Transdermal Testosterone Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Transdermal Testosterone Sales by Country (2019-2030)
3.7.3 Latin America Transdermal Testosterone Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Transdermal Testosterone Market Facts & Figures by Country
3.8.1 Middle East and Africa Transdermal Testosterone Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Transdermal Testosterone Sales by Country (2019-2030)
3.8.3 Middle East and Africa Transdermal Testosterone Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Transdermal Testosterone Sales by Type (2019-2030)
4.1.1 Global Transdermal Testosterone Sales by Type (2019-2024)
4.1.2 Global Transdermal Testosterone Sales by Type (2025-2030)
4.1.3 Global Transdermal Testosterone Sales Market Share by Type (2019-2030)
4.2 Global Transdermal Testosterone Revenue by Type (2019-2030)
4.2.1 Global Transdermal Testosterone Revenue by Type (2019-2024)
4.2.2 Global Transdermal Testosterone Revenue by Type (2025-2030)
4.2.3 Global Transdermal Testosterone Revenue Market Share by Type (2019-2030)
4.3 Global Transdermal Testosterone Price by Type (2019-2030)
5 Segment by Application
5.1 Global Transdermal Testosterone Sales by Application (2019-2030)
5.1.1 Global Transdermal Testosterone Sales by Application (2019-2024)
5.1.2 Global Transdermal Testosterone Sales by Application (2025-2030)
5.1.3 Global Transdermal Testosterone Sales Market Share by Application (2019-2030)
5.2 Global Transdermal Testosterone Revenue by Application (2019-2030)
5.2.1 Global Transdermal Testosterone Revenue by Application (2019-2024)
5.2.2 Global Transdermal Testosterone Revenue by Application (2025-2030)
5.2.3 Global Transdermal Testosterone Revenue Market Share by Application (2019-2030)
5.3 Global Transdermal Testosterone Price by Application (2019-2030)
6 Key Companies Profiled
6.1 AbbVie
6.1.1 AbbVie Corporation Information
6.1.2 AbbVie Description and Business Overview
6.1.3 AbbVie Transdermal Testosterone Sales, Revenue and Gross Margin (2019-2024)
6.1.4 AbbVie Transdermal Testosterone Product Portfolio
6.1.5 AbbVie Recent Developments/Updates
6.2 Teva
6.2.1 Teva Corporation Information
6.2.2 Teva Description and Business Overview
6.2.3 Teva Transdermal Testosterone Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Teva Transdermal Testosterone Product Portfolio
6.2.5 Teva Recent Developments/Updates
6.3 Perrigo
6.3.1 Perrigo Corporation Information
6.3.2 Perrigo Description and Business Overview
6.3.3 Perrigo Transdermal Testosterone Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Perrigo Transdermal Testosterone Product Portfolio
6.3.5 Perrigo Recent Developments/Updates
6.4 Endo Pharmaceuticals
6.4.1 Endo Pharmaceuticals Corporation Information
6.4.2 Endo Pharmaceuticals Description and Business Overview
6.4.3 Endo Pharmaceuticals Transdermal Testosterone Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Endo Pharmaceuticals Transdermal Testosterone Product Portfolio
6.4.5 Endo Pharmaceuticals Recent Developments/Updates
6.5 Acerus Pharmaceuticals
6.5.1 Acerus Pharmaceuticals Corporation Information
6.5.2 Acerus Pharmaceuticals Description and Business Overview
6.5.3 Acerus Pharmaceuticals Transdermal Testosterone Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Acerus Pharmaceuticals Transdermal Testosterone Product Portfolio
6.5.5 Acerus Pharmaceuticals Recent Developments/Updates
6.6 Lupin
6.6.1 Lupin Corporation Information
6.6.2 Lupin Description and Business Overview
6.6.3 Lupin Transdermal Testosterone Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Lupin Transdermal Testosterone Product Portfolio
6.6.5 Lupin Recent Developments/Updates
6.7 Dr. Reddy's Laboratories
6.6.1 Dr. Reddy's Laboratories Corporation Information
6.6.2 Dr. Reddy's Laboratories Description and Business Overview
6.6.3 Dr. Reddy's Laboratories Transdermal Testosterone Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Dr. Reddy's Laboratories Transdermal Testosterone Product Portfolio
6.7.5 Dr. Reddy's Laboratories Recent Developments/Updates
6.8 Upsher-Smith Laboratories
6.8.1 Upsher-Smith Laboratories Corporation Information
6.8.2 Upsher-Smith Laboratories Description and Business Overview
6.8.3 Upsher-Smith Laboratories Transdermal Testosterone Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Upsher-Smith Laboratories Transdermal Testosterone Product Portfolio
6.8.5 Upsher-Smith Laboratories Recent Developments/Updates
6.9 Allergan
6.9.1 Allergan Corporation Information
6.9.2 Allergan Description and Business Overview
6.9.3 Allergan Transdermal Testosterone Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Allergan Transdermal Testosterone Product Portfolio
6.9.5 Allergan Recent Developments/Updates
6.10 Cipla Inc.
6.10.1 Cipla Inc. Corporation Information
6.10.2 Cipla Inc. Description and Business Overview
6.10.3 Cipla Inc. Transdermal Testosterone Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Cipla Inc. Transdermal Testosterone Product Portfolio
6.10.5 Cipla Inc. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Transdermal Testosterone Industry Chain Analysis
7.2 Transdermal Testosterone Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Transdermal Testosterone Production Mode & Process
7.4 Transdermal Testosterone Sales and Marketing
7.4.1 Transdermal Testosterone Sales Channels
7.4.2 Transdermal Testosterone Distributors
7.5 Transdermal Testosterone Customers
8 Transdermal Testosterone Market Dynamics
8.1 Transdermal Testosterone Industry Trends
8.2 Transdermal Testosterone Market Drivers
8.3 Transdermal Testosterone Market Challenges
8.4 Transdermal Testosterone Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
AbbVie
TEVA
Perrigo
Endo Pharmaceuticals
Acerus Pharmaceuticals
Lupin Ltd
Dr. Reddy’s Laboratories
Upsher-Smith Laboratories
Allergan plc
Cipla Ltd
List of Tables
    Table 1. Global Transdermal Testosterone Market Value Comparison by Type (2024-2030) & (US$ Million)
    Table 2. Global Transdermal Testosterone Market Value Comparison by Application (2024-2030) & (US$ Million)
    Table 3. Global Transdermal Testosterone Market Competitive Situation by Manufacturers in 2023
    Table 4. Global Transdermal Testosterone Sales (K Units) of Key Manufacturers (2019-2024)
    Table 5. Global Transdermal Testosterone Sales Market Share by Manufacturers (2019-2024)
    Table 6. Global Transdermal Testosterone Revenue (US$ Million) by Manufacturers (2019-2024)
    Table 7. Global Transdermal Testosterone Revenue Share by Manufacturers (2019-2024)
    Table 8. Global Market Transdermal Testosterone Average Price (USD/Unit) of Key Manufacturers (2019-2024)
    Table 9. Global Key Players of Transdermal Testosterone, Industry Ranking, 2022 VS 2023 VS 2024
    Table 10. Global Key Manufacturers of Transdermal Testosterone, Manufacturing Sites & Headquarters
    Table 11. Global Key Manufacturers of Transdermal Testosterone, Product Type & Application
    Table 12. Global Key Manufacturers of Transdermal Testosterone, Date of Enter into This Industry
    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Transdermal Testosterone by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Transdermal Testosterone as of 2023)
    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 16. Global Transdermal Testosterone Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 17. Global Transdermal Testosterone Sales by Region (2019-2024) & (K Units)
    Table 18. Global Transdermal Testosterone Sales Market Share by Region (2019-2024)
    Table 19. Global Transdermal Testosterone Sales by Region (2025-2030) & (K Units)
    Table 20. Global Transdermal Testosterone Sales Market Share by Region (2025-2030)
    Table 21. Global Transdermal Testosterone Revenue by Region (2019-2024) & (US$ Million)
    Table 22. Global Transdermal Testosterone Revenue Market Share by Region (2019-2024)
    Table 23. Global Transdermal Testosterone Revenue by Region (2025-2030) & (US$ Million)
    Table 24. Global Transdermal Testosterone Revenue Market Share by Region (2025-2030)
    Table 25. North America Transdermal Testosterone Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 26. North America Transdermal Testosterone Sales by Country (2019-2024) & (K Units)
    Table 27. North America Transdermal Testosterone Sales by Country (2025-2030) & (K Units)
    Table 28. North America Transdermal Testosterone Revenue by Country (2019-2024) & (US$ Million)
    Table 29. North America Transdermal Testosterone Revenue by Country (2025-2030) & (US$ Million)
    Table 30. Europe Transdermal Testosterone Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 31. Europe Transdermal Testosterone Sales by Country (2019-2024) & (K Units)
    Table 32. Europe Transdermal Testosterone Sales by Country (2025-2030) & (K Units)
    Table 33. Europe Transdermal Testosterone Revenue by Country (2019-2024) & (US$ Million)
    Table 34. Europe Transdermal Testosterone Revenue by Country (2025-2030) & (US$ Million)
    Table 35. Asia Pacific Transdermal Testosterone Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 36. Asia Pacific Transdermal Testosterone Sales by Region (2019-2024) & (K Units)
    Table 37. Asia Pacific Transdermal Testosterone Sales by Region (2025-2030) & (K Units)
    Table 38. Asia Pacific Transdermal Testosterone Revenue by Region (2019-2024) & (US$ Million)
    Table 39. Asia Pacific Transdermal Testosterone Revenue by Region (2025-2030) & (US$ Million)
    Table 40. Latin America Transdermal Testosterone Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Latin America Transdermal Testosterone Sales by Country (2019-2024) & (K Units)
    Table 42. Latin America Transdermal Testosterone Sales by Country (2025-2030) & (K Units)
    Table 43. Latin America Transdermal Testosterone Revenue by Country (2019-2024) & (US$ Million)
    Table 44. Latin America Transdermal Testosterone Revenue by Country (2025-2030) & (US$ Million)
    Table 45. Middle East & Africa Transdermal Testosterone Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 46. Middle East & Africa Transdermal Testosterone Sales by Country (2019-2024) & (K Units)
    Table 47. Middle East & Africa Transdermal Testosterone Sales by Country (2025-2030) & (K Units)
    Table 48. Middle East & Africa Transdermal Testosterone Revenue by Country (2019-2024) & (US$ Million)
    Table 49. Middle East & Africa Transdermal Testosterone Revenue by Country (2025-2030) & (US$ Million)
    Table 50. Global Transdermal Testosterone Sales (K Units) by Type (2019-2024)
    Table 51. Global Transdermal Testosterone Sales (K Units) by Type (2025-2030)
    Table 52. Global Transdermal Testosterone Sales Market Share by Type (2019-2024)
    Table 53. Global Transdermal Testosterone Sales Market Share by Type (2025-2030)
    Table 54. Global Transdermal Testosterone Revenue (US$ Million) by Type (2019-2024)
    Table 55. Global Transdermal Testosterone Revenue (US$ Million) by Type (2025-2030)
    Table 56. Global Transdermal Testosterone Revenue Market Share by Type (2019-2024)
    Table 57. Global Transdermal Testosterone Revenue Market Share by Type (2025-2030)
    Table 58. Global Transdermal Testosterone Price (USD/Unit) by Type (2019-2024)
    Table 59. Global Transdermal Testosterone Price (USD/Unit) by Type (2025-2030)
    Table 60. Global Transdermal Testosterone Sales (K Units) by Application (2019-2024)
    Table 61. Global Transdermal Testosterone Sales (K Units) by Application (2025-2030)
    Table 62. Global Transdermal Testosterone Sales Market Share by Application (2019-2024)
    Table 63. Global Transdermal Testosterone Sales Market Share by Application (2025-2030)
    Table 64. Global Transdermal Testosterone Revenue (US$ Million) by Application (2019-2024)
    Table 65. Global Transdermal Testosterone Revenue (US$ Million) by Application (2025-2030)
    Table 66. Global Transdermal Testosterone Revenue Market Share by Application (2019-2024)
    Table 67. Global Transdermal Testosterone Revenue Market Share by Application (2025-2030)
    Table 68. Global Transdermal Testosterone Price (USD/Unit) by Application (2019-2024)
    Table 69. Global Transdermal Testosterone Price (USD/Unit) by Application (2025-2030)
    Table 70. AbbVie Corporation Information
    Table 71. AbbVie Description and Business Overview
    Table 72. AbbVie Transdermal Testosterone Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 73. AbbVie Transdermal Testosterone Product
    Table 74. AbbVie Recent Developments/Updates
    Table 75. Teva Corporation Information
    Table 76. Teva Description and Business Overview
    Table 77. Teva Transdermal Testosterone Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 78. Teva Transdermal Testosterone Product
    Table 79. Teva Recent Developments/Updates
    Table 80. Perrigo Corporation Information
    Table 81. Perrigo Description and Business Overview
    Table 82. Perrigo Transdermal Testosterone Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 83. Perrigo Transdermal Testosterone Product
    Table 84. Perrigo Recent Developments/Updates
    Table 85. Endo Pharmaceuticals Corporation Information
    Table 86. Endo Pharmaceuticals Description and Business Overview
    Table 87. Endo Pharmaceuticals Transdermal Testosterone Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 88. Endo Pharmaceuticals Transdermal Testosterone Product
    Table 89. Endo Pharmaceuticals Recent Developments/Updates
    Table 90. Acerus Pharmaceuticals Corporation Information
    Table 91. Acerus Pharmaceuticals Description and Business Overview
    Table 92. Acerus Pharmaceuticals Transdermal Testosterone Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 93. Acerus Pharmaceuticals Transdermal Testosterone Product
    Table 94. Acerus Pharmaceuticals Recent Developments/Updates
    Table 95. Lupin Corporation Information
    Table 96. Lupin Description and Business Overview
    Table 97. Lupin Transdermal Testosterone Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 98. Lupin Transdermal Testosterone Product
    Table 99. Lupin Recent Developments/Updates
    Table 100. Dr. Reddy's Laboratories Corporation Information
    Table 101. Dr. Reddy's Laboratories Description and Business Overview
    Table 102. Dr. Reddy's Laboratories Transdermal Testosterone Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 103. Dr. Reddy's Laboratories Transdermal Testosterone Product
    Table 104. Dr. Reddy's Laboratories Recent Developments/Updates
    Table 105. Upsher-Smith Laboratories Corporation Information
    Table 106. Upsher-Smith Laboratories Description and Business Overview
    Table 107. Upsher-Smith Laboratories Transdermal Testosterone Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 108. Upsher-Smith Laboratories Transdermal Testosterone Product
    Table 109. Upsher-Smith Laboratories Recent Developments/Updates
    Table 110. Allergan Corporation Information
    Table 111. Allergan Description and Business Overview
    Table 112. Allergan Transdermal Testosterone Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 113. Allergan Transdermal Testosterone Product
    Table 114. Allergan Recent Developments/Updates
    Table 115. Cipla Inc. Corporation Information
    Table 116. Cipla Inc. Description and Business Overview
    Table 117. Cipla Inc. Transdermal Testosterone Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 118. Cipla Inc. Transdermal Testosterone Product
    Table 119. Cipla Inc. Recent Developments/Updates
    Table 120. Key Raw Materials Lists
    Table 121. Raw Materials Key Suppliers Lists
    Table 122. Transdermal Testosterone Distributors List
    Table 123. Transdermal Testosterone Customers List
    Table 124. Transdermal Testosterone Market Trends
    Table 125. Transdermal Testosterone Market Drivers
    Table 126. Transdermal Testosterone Market Challenges
    Table 127. Transdermal Testosterone Market Restraints
    Table 128. Research Programs/Design for This Report
    Table 129. Key Data Information from Secondary Sources
    Table 130. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Transdermal Testosterone
    Figure 2. Global Transdermal Testosterone Market Value Comparison by Type (2024-2030) & (US$ Million)
    Figure 3. Global Transdermal Testosterone Market Share by Type in 2023 & 2030
    Figure 4. Gel Product Picture
    Figure 5. Patch Product Picture
    Figure 6. Global Transdermal Testosterone Market Value Comparison by Application (2024-2030) & (US$ Million)
    Figure 7. Global Transdermal Testosterone Market Share by Application in 2023 & 2030
    Figure 8. Primary Hypogonadism
    Figure 9. Hypogonadotropic Hypogonadism
    Figure 10. Late-Onset Hypogonadism
    Figure 11. Global Transdermal Testosterone Revenue, (US$ Million), 2019 VS 2023 VS 2030
    Figure 12. Global Transdermal Testosterone Market Size (2019-2030) & (US$ Million)
    Figure 13. Global Transdermal Testosterone Sales (2019-2030) & (K Units)
    Figure 14. Global Transdermal Testosterone Average Price (USD/Unit) & (2019-2030)
    Figure 15. Transdermal Testosterone Report Years Considered
    Figure 16. Transdermal Testosterone Sales Share by Manufacturers in 2023
    Figure 17. Global Transdermal Testosterone Revenue Share by Manufacturers in 2023
    Figure 18. The Global 5 and 10 Largest Transdermal Testosterone Players: Market Share by Revenue in 2023
    Figure 19. Transdermal Testosterone Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
    Figure 20. Global Transdermal Testosterone Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Figure 21. North America Transdermal Testosterone Sales Market Share by Country (2019-2030)
    Figure 22. North America Transdermal Testosterone Revenue Market Share by Country (2019-2030)
    Figure 23. U.S. Transdermal Testosterone Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 24. Canada Transdermal Testosterone Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 25. Europe Transdermal Testosterone Sales Market Share by Country (2019-2030)
    Figure 26. Europe Transdermal Testosterone Revenue Market Share by Country (2019-2030)
    Figure 27. Germany Transdermal Testosterone Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 28. France Transdermal Testosterone Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 29. U.K. Transdermal Testosterone Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 30. Italy Transdermal Testosterone Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 31. Russia Transdermal Testosterone Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 32. Asia Pacific Transdermal Testosterone Sales Market Share by Region (2019-2030)
    Figure 33. Asia Pacific Transdermal Testosterone Revenue Market Share by Region (2019-2030)
    Figure 34. China Transdermal Testosterone Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 35. Japan Transdermal Testosterone Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 36. South Korea Transdermal Testosterone Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 37. India Transdermal Testosterone Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 38. Australia Transdermal Testosterone Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 39. Taiwan Transdermal Testosterone Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 40. Indonesia Transdermal Testosterone Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 41. Thailand Transdermal Testosterone Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 42. Malaysia Transdermal Testosterone Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 43. Philippines Transdermal Testosterone Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 44. Latin America Transdermal Testosterone Sales Market Share by Country (2019-2030)
    Figure 45. Latin America Transdermal Testosterone Revenue Market Share by Country (2019-2030)
    Figure 46. Mexico Transdermal Testosterone Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 47. Brazil Transdermal Testosterone Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 48. Argentina Transdermal Testosterone Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 49. Middle East & Africa Transdermal Testosterone Sales Market Share by Country (2019-2030)
    Figure 50. Middle East & Africa Transdermal Testosterone Revenue Market Share by Country (2019-2030)
    Figure 51. Turkey Transdermal Testosterone Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 52. Saudi Arabia Transdermal Testosterone Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 53. UAE Transdermal Testosterone Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 54. Global Sales Market Share of Transdermal Testosterone by Type (2019-2030)
    Figure 55. Global Revenue Market Share of Transdermal Testosterone by Type (2019-2030)
    Figure 56. Global Transdermal Testosterone Price (USD/Unit) by Type (2019-2030)
    Figure 57. Global Sales Market Share of Transdermal Testosterone by Application (2019-2030)
    Figure 58. Global Revenue Market Share of Transdermal Testosterone by Application (2019-2030)
    Figure 59. Global Transdermal Testosterone Price (USD/Unit) by Application (2019-2030)
    Figure 60. Transdermal Testosterone Value Chain
    Figure 61. Transdermal Testosterone Production Process
    Figure 62. Channels of Distribution (Direct Vs Distribution)
    Figure 63. Distributors Profiles
    Figure 64. Bottom-up and Top-down Approaches for This Report
    Figure 65. Data Triangulation
    Figure 66. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Medical Implantable Drug Infusion Pump - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-34A13945
Thu May 02 00:00:00 UTC 2024

Add to Cart

Pre-filled Flush Syringes(≤5ml) - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-31G14124
Thu May 02 00:00:00 UTC 2024

Add to Cart

OTC Topical Antifungals - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-32D13978
Tue Apr 30 00:00:00 UTC 2024

Add to Cart

Fluoxetine Capsules - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-2J14387
Tue Apr 30 00:00:00 UTC 2024

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions